Metraipolis › archive › dc_40c5879de4ae
Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab — Europe PMC PMID:41070726
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41070726
- DOI
- 10.1002/brb3.70950
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:13:47.208Z
- SHA-256 of the archived text
df41a92c0be108e0d08cfde078419a24828f3461a53e6927d368ed58c5818d67- Stable URL of this page
https://metraipolis.com/documento/dc_40c5879de4ae
How to cite
Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab — Europe PMC PMID:41070726 — Europe PMC (en), https://europepmc.org/article/MED/41070726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40c5879de4ae (Metraipolis archive dc_40c5879de4ae, sha256 df41a92c0be108e0d08cfde078419a24828f3461a53e6927d368ed58c5818d67)
BibTeX
@misc{dc40c5879de4ae,
title = {Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab — Europe PMC PMID:41070726},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41070726},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40c5879de4ae; sha256 df41a92c0be108e0d08cfde078419a24828f3461a53e6927d368ed58c5818d67},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41070726. Agents can read the archived copy with the MCP tool read_document.